These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17823749

  • 1. Withdrawal of maintenance therapy for cytomegalovirus retinitis in AIDS patients exhibiting immunological response to HAART.
    Waib LF, Bonon SH, Salles AC, Benard G, de Oliveira AC, Pannuti CS, Pedro Rde J, Costa SC.
    Rev Inst Med Trop Sao Paulo; 2007; 49(4):215-9. PubMed ID: 17823749
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 6. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL, Raboud J, Angel JB, Mazzulli T, Shen S, Casciaro L, Young CD, Moussa G, Gough K, Rachlis A, Hopkins J.
    HIV Clin Trials; 2006 Nov 03; 7(1):1-9. PubMed ID: 16632459
    [Abstract] [Full Text] [Related]

  • 7. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 03; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 May 03; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]

  • 10. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients.
    Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B.
    J Infect Dis; 1998 Apr 03; 177(4):1080-3. PubMed ID: 9534987
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May 03; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 13. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun 03; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 14. Recovery of long-term natural protection against reactivation of CMV retinitis in AIDS patients responding to highly active antiretroviral therapy.
    Di Perri G, Vento S, Mazzi R, Bonora S, Bonora A, Trevenzoli M, Allegranzi B, Carretta G, Lanzafame M, Pizzighella S, Concia E.
    J Infect; 1999 Nov 03; 39(3):193-7. PubMed ID: 10714794
    [Abstract] [Full Text] [Related]

  • 15. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul 03; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy.
    Salmon-Céron D, Mazeron MC, Chaput S, Boukli N, Senechal B, Houhou N, Katlama C, Matheron S, Fillet AM, Gozlan J, Leport C, Jeantils V, Freymuth F, Costagliola D.
    AIDS; 2000 May 26; 14(8):1041-9. PubMed ID: 10853987
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of highly active antiretroviral therapy on cytomegalovirus antigenaemia in AIDS patients.
    Borges LH, Villas Boas LS, Warren-Santoro SH, Estevam MP, Uip DE, Savalli C, Curi M, Pannuti CS.
    Int J STD AIDS; 2001 Apr 26; 12(4):234-8. PubMed ID: 11319974
    [Abstract] [Full Text] [Related]

  • 20. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2004 Dec 26; 111(12):2224-31. PubMed ID: 15582078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.